Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Iain Gladstone Ross is a British businessperson who founded Biomer Technology Ltd. and who has been at the head of 19 different companies. Presently, he holds the position of Chairman for Kazia Therapeutics Ltd., Non-Executive Chairman of ReNeuron Group Plc, Non-Executive Chairman for Silence Therapeutics Plc, Chairman of Biomer Technology Ltd., Non-Executive Chairman for Motif Bio Plc, Chairman at Novagen Ltd. and Non-Executive Chairman at BiVictriX Therapeutics Plc. Iain Gladstone Ross is also on the board of Palla Pharma Ltd., Redx Oncology Ltd. and Gladstone Partners Ltd.

In the past Mr. Ross was Non-Executive Chairman at Smartspace Software Plc, Non-Executive Chairman of e-Therapeutics Plc, Executive Chairman for Silence Therapeutics Plc, Non-Executive Chairman of Pharminox Ltd, Non-Executive Director at Premier Veterinary Group Plc and Non-Executive Chairman for Ark Therapeutics Group Plc (a subsidiary of Premier Veterinary Group Plc), Chairman & Chief Executive Officer for Sandoz AG, Non-Executive Chairman for Redx Pharma Plc, Chief Executive Officer of Reed Business Information Ltd., Chief Executive Officer at Lonza Biologics Plc, Chief Executive Officer for Hoffman-La Roche, Inc., Chief Executive Officer of Quadrant Healthcare Plc, Principal at Fisons Plc, Vice Chairman-Council of Royal Holloway at the University of London, Vice Chairman-Council at Royal Holloway University of London and Chartered Director at The Institute of Directors (United Kingdom).

Iain Gladstone Ross received an undergraduate degree from the University of London.


Posti e reponsabilitÓ di Iain Gladstone Ross 
NomeTitolo Da
Silence Therapeutics plc
(Biotecnologia)
Non-Executive Chairman 2020
ReNeuron Group plc
(Biotecnologia)
Non-Executive Chairman 2021
Kazia Therapeutics Limited
(Biotecnologia)
Chairman 2017
BiVictriX Therapeutics Plc
(Biotecnologia)
Non-Executive Chairman 2021
Palla Pharma Limited
(Prodotti farmaceutici)
Independent Non-Executive Director -
Motif Bio plc
(Biotecnologia)
Non-Executive Chairman 2021
Biomer Technology Ltd. Chairman 2012
Novagen Ltd. Chairman -
Redx Oncology Ltd. Director -
Gladstone Partners Ltd. Director -


Participazioni di Iain Gladstone Ross 
NomeAzioni%Valorizzazione
Kazia Therapeutics Limited (KZA)
(Biotecnologia)
1 000 0010,75%1 130 481 USD
e-therapeutics plc (ETX)
(Biotecnologia)
1 700 0000,33%814 878 USD
Silence Therapeutics plc (SLN)
(Biotecnologia)
54 4430,061%382 457 USD
Redx Pharma Plc (REDX)
(Biotecnologia)
215 8700,078%248 864 USD
Palla Pharma Limited (PAL)
(Prodotti farmaceutici)
75 0000,046%18 962 USD


Iain Gladstone Ross: network personale 
Le notizie pi¨ lette 
15/10JACK DORSEY: Il CEO di Square Dorsey dice che sta cercando di costruire un sistema di estrazione di bitcoin - tweet
MR
12/10CATHIE WOOD: Wood di ARK Invest avverte che la prossima flessione economica in Cina è "ovvia".
MR
12/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore", dovuto alla regolamentazione
MR
13/10WARREN BUFFETT: Nubank, sostenuta da Buffett, realizza un profitto in Brasile
MR
11/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore
MR
07/10ROBERT WALTERS: Il reclutatore Robert Walters si aspetta che il profitto batta le stime in mezzo al caldo mercato del lavoro
MR
06/10CARL ICAHN: Dominion venderà Questar a Southwest Gas in un affare da quasi 2 miliardi di dollari
MR
08/10LEONARDO DEL VECCHIO: Generali, Del Vecchio arrotonda quota di ulteriore 0,08%, sale al 5,4%
RE
06/10ALFREDO ALTAVILLA: Ita dialoga con Fs su intermodalità, biglietto unico punto arrivo ideale - Altavilla
RE
Pi¨ notizie


© 2021 People and Ownership :   
Iain Gladstone Ross : connessioni